Though Kymera Therapeutics is increasing its cash burn and s...

Moomoo AI Oct 29, 2023 09:52

Though Kymera Therapeutics is increasing its cash burn and seeing reduced operating revenue, it's still well positioned. However, potential share dilution from issuing new shares to cover a year's operations could deter future investors.

Here's Why We're Watching Kymera Therapeutics' (NASDAQ:KYMR) Cash Burn Situation

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

2186 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

3240Followers

0Following

8006Visitors